EDAP TMS S.A ROA 2010-2024 | EDAP
Current and historical return on assets (ROA) values for EDAP TMS S.A (EDAP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| EDAP TMS S.A ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $-0.02B | $0.09B | -25.74% |
| 2024-06-30 | $-0.02B | $0.09B | -21.88% |
| 2024-03-31 | $-0.02B | $0.10B | -19.00% |
| 2023-12-31 | $-0.02B | $0.10B | -21.26% |
| 2023-09-30 | $-0.02B | $0.10B | -20.90% |
| 2023-06-30 | $-0.02B | $0.10B | -16.94% |
| 2023-03-31 | $-0.01B | $0.11B | -10.84% |
| 2022-12-31 | $-0.00B | $0.11B | -3.15% |
| 2022-09-30 | $0.00B | $0.10B | 4.44% |
| 2022-06-30 | $0.00B | $0.09B | 3.51% |
| 2022-03-31 | $0.00B | $0.09B | 0.00% |
| 2021-12-31 | $0.00B | $0.09B | 1.24% |
| 2021-09-30 | $0.00B | $0.09B | 0.00% |
| 2021-06-30 | $0.00B | $0.09B | 0.00% |
| 2021-03-31 | $0.00B | $0.06B | 2.09% |
| 2020-12-31 | $-0.00B | $0.07B | -3.13% |
| 2020-09-30 | $-0.00B | $0.06B | -10.00% |
| 2020-06-30 | $-0.00B | $0.00B | -6.78% |
| 2020-03-31 | $0.00B | $0.00B | 6.78% |
| 2019-12-31 | $0.00B | $0.06B | 13.56% |
| 2019-09-30 | $0.00B | $0.00B | 27.59% |
| 2019-06-30 | $0.00B | $0.00B | 13.79% |
| 2019-03-31 | $-0.00B | $0.00B | -3.51% |
| 2018-12-31 | $-0.00B | $0.06B | -3.51% |
| 2018-09-30 | $-0.00B | $0.00B | -7.34% |
| 2018-06-30 | $-0.00B | $0.06B | -7.34% |
| 2018-03-31 | $-0.00B | $0.00B | -11.65% |
| 2017-12-31 | $-0.00B | $0.05B | -3.88% |
| 2017-09-30 | $-0.00B | $0.00B | -7.84% |
| 2017-06-30 | $0.00B | $0.05B | 0.00% |
| 2017-03-31 | $0.01B | $0.00B | 19.05% |
| 2016-12-31 | $0.01B | $0.05B | 19.05% |
| 2016-09-30 | $0.01B | $0.00B | 50.00% |
| 2016-06-30 | $0.01B | $0.05B | 25.00% |
| 2016-03-31 | $0.00B | $0.00B | 19.75% |
| 2015-12-31 | $-0.00B | $0.04B | -4.94% |
| 2015-09-30 | $-0.01B | $0.00B | -49.38% |
| 2015-06-30 | $0.00B | $0.04B | 19.75% |
| 2015-03-31 | $-0.00B | $0.00B | -18.18% |
| 2014-12-31 | $-0.00B | $0.04B | 0.00% |
| 2014-09-30 | $0.00B | $0.00B | 9.88% |
| 2014-06-30 | $-0.01B | $0.05B | -34.57% |
| 2014-03-31 | $0.00B | $0.00B | 0.00% |
| 2013-12-31 | $-0.01B | $0.04B | -24.00% |
| 2013-09-30 | $-0.01B | $0.00B | -23.30% |
| 2013-06-30 | $-0.01B | $0.04B | -20.74% |
| 2013-03-31 | $-0.01B | $0.03B | -30.08% |
| 2012-12-31 | $-0.01B | $0.04B | -25.71% |
| 2012-09-30 | $-0.01B | $0.03B | -24.66% |
| 2012-06-30 | $-0.01B | $0.03B | -18.79% |
| 2012-03-31 | $-0.01B | $0.04B | -15.00% |
| 2011-12-31 | $-0.00B | $0.05B | -4.91% |
| 2011-09-30 | $-0.01B | $0.04B | -26.51% |
| 2011-06-30 | $-0.01B | $0.04B | -32.94% |
| 2011-03-31 | $-0.01B | $0.04B | -29.55% |
| 2010-12-31 | $-0.02B | $0.05B | -37.99% |
| 2010-09-30 | $-0.01B | $0.04B | -10.70% |
| 2010-06-30 | $-0.01B | $0.05B | -23.04% |
| 2010-03-31 | $-0.01B | $0.04B | -22.45% |
| 2009-12-31 | $-0.01B | $0.06B | -22.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.101B | $0.065B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.048B | 99.11 |
| Thermo Fisher Scientific (TMO) | United States | $205.720B | 24.60 |
| Alcon (ALC) | Switzerland | $44.180B | 29.56 |
| Edwards Lifesciences (EW) | United States | $44.064B | 28.51 |
| IDEXX Laboratories (IDXX) | United States | $37.082B | 42.44 |
| DexCom (DXCM) | United States | $34.912B | 54.15 |
| IQVIA Holdings (IQV) | United States | $34.165B | 18.93 |
| Mettler-Toledo (MTD) | United States | $27.257B | 31.66 |
| Waters (WAT) | United States | $22.611B | 32.08 |
| STERIS (STE) | Ireland | $21.693B | 24.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.328B | 0.00 |
| Hologic (HOLX) | United States | $14.433B | 15.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.462B | 13.82 |
| Penumbra (PEN) | United States | $11.675B | 105.62 |
| Sysmex ADR (SSMXY) | Japan | $11.519B | 36.12 |
| Globus Medical (GMED) | United States | $11.454B | 26.79 |
| Masimo (MASI) | United States | $9.488B | 45.91 |
| Glaukos (GKOS) | United States | $8.676B | 0.00 |
| Teleflex (TFX) | United States | $8.134B | 12.97 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.536B | 25.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.412B | 0.00 |
| Veracyte (VCYT) | United States | $3.181B | 95.46 |
| Nihon Kohden (NHNKY) | Japan | $2.671B | 14.60 |
| LivaNova (LIVN) | United Kingdom | $2.606B | 15.04 |
| TransMedics (TMDX) | United States | $2.532B | 80.27 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 21.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.110B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.700B | 8.88 |
| Alphatec Holdings (ATEC) | United States | $1.512B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.230B | 0.00 |
| RxSight (RXST) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.208B | 80.06 |
| OPKO Health (OPK) | United States | $1.140B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.894B | 0.00 |
| AxoGen (AXGN) | United States | $0.814B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.793B | 17.33 |
| SiBone (SIBN) | United States | $0.755B | 0.00 |
| IRadimed (IRMD) | United States | $0.724B | 38.09 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.711B | 12.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.497B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| ClearPoint Neuro (CLPT) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.425B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.363B | 19.47 |
| Anteris Technologies Global (AVR) | Australia | $0.297B | 0.00 |
| Inogen (INGN) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.222B | 0.00 |
| Nevro (NVRO) | United States | $0.215B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.140B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 13.90 |
| Lucid Diagnostics (LUCD) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| Hyperfine (HYPR) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 32.14 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |